Verum Partners’s Gilead Sciences GILD Stock Holding History

Verum Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Buy	+1,603	New	+$211K	0.03%	196

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Verum Partners's GILD Position: Q2 2026 in Review

Verum Partners opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,603 shares worth $202K. The stake represents 0.03% of the portfolio and ranks #196 among its holdings.

619 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Verum Partners held 1,603 shares of Gilead Sciences worth $202K as of Q2 2026.
Gilead Sciences was a new Verum Partners position in Q2 2026.
Gilead Sciences made up 0.03% of Verum Partners's portfolio in Q2 2026, its #196 holding.
619 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.